查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1946626

2026年全球新型药物递送系统市场报告

Novel Drug Delivery Systems Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，新型药物递送系统的市场规模迅速扩张，预计将从2025年的1,176.6亿美元成长到2026年的1,294.5亿美元，复合年增长率达10.0%。过去几年的成长可归因于慢性病盛行率的上升、传统药物递送方法的局限性、肿瘤和生物製药研发管线的扩展、医疗保健成本的上涨以及聚合物和奈米技术的进步。

预计未来几年，新型药物递送系统市场将维持强劲成长，2030年市场规模将达到1,875.3亿美元，复合年增长率（CAGR）为9.7%。预测期内的成长主要受以下因素驱动：个人化和精准医疗的蓬勃发展、标靶癌症治疗需求的成长、药物研发投入的增加、生物製剂和生物相似药的扩张，以及监管机构对先进药物递送技术的支持。预测期内的关键趋势包括：标靶化和个人化药物递送的扩展、脂质和聚合物奈米颗粒应用的日益普及、缓释製剂的增长、对非侵入性和以患者为中心的给药途径的日益关注，以及组合式和混合式新型药物递送系统（NDDS）平台研发的加速。

神经系统疾病发生率的不断上升预计将推动新型药物递送系统市场的成长。神经系统疾病，例如中风，其特征是由于脑部血流中断而导致的神经功能突然丧失。这可能是由血管阻塞（缺血性中风）或血管破裂（出血性中风）引起的，并可能导致脑损伤以及认知、感觉和运动定向的长期损害。导致神经系统疾病发生率上升的因素包括血脑障壁老化、高血压、糖尿病和肥胖等文明病疾病的增加，以及慢性压力和环境风险的增加。新型药物递送系统可以透过实现标靶和可控的药物递送，帮助治疗这些疾病。例如，根据英国国家医疗服务体系（NHS）2024年11月发布的数据，2023/24年度英格兰地区因中风住院的患者人数将达到111,137人，其中50-59岁年龄组的增幅最为显着，新增病例达12,533例。神经系统疾病发生率的上升正在推动新型药物输送系统市场的成长。

新型药物递送系统市场的主要企业正透过口腔薄膜等产品进行创新，以提高患者依从性和治疗效果。口腔薄膜是一种快速溶解的贴片，贴于口腔内，透过黏膜层将药物直接输送到血液中。例如，2024年2月，美国製剂研发公司CD Formulation推出了其「口腔薄膜技术」。该技术能够绕过消化道和肝臟的代谢，使药物快速吸收，非常适合吞嚥困难的患者。此外，它还能达到精准的剂量控制和更短的起效时间，进而提高各种治疗方法的治疗精准性和便利性。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球新型药物递送系统市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧（AI）和自主人工智慧
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 永续性、气候技术和循环经济
  • 主要趋势
    • 扩大标靶化和个人化药物递送
    • 脂质和聚合物奈米粒子的应用日益广泛
    • 缓释製剂的成长
    • 越来越重视非侵入性和以病人为中心的治疗途径
    • 加速组合式与混合式NDD平台的研究与开发

第五章 终端用户产业市场分析

  • 医院
  • 专科诊所
  • 製药公司
  • 生技公司
  • 研究中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球新型药物递送系统市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 全球新型药物递送系统市场规模、比较及成长率分析
  • 全球新型药物递送系统市场表现：规模与成长，2020-2025年
  • 全球新型药物递送系统市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场规模（TAM）

第九章 市场细分

  • 依配方类型
  • 脂质体、奈米颗粒、微球、水凝胶、树状聚合物
  • 新型药物递送系统（NDDS）依模式
  • 标靶药物递送系统、控释药物递送系统、调节药物传递系统
  • 沿途
  • 口服给药系统、注射给药系统、肺部给药系统、经皮给药系统、其他给药途径
  • 透过癒合区域
  • 癌症、心血管疾病、神经系统疾病、感染疾病、自体免疫疾病
  • 最终用户
  • 医院、专科诊所、研究中心和其他最终用户
  • 按类型细分：脂质体
  • 聚乙二醇化脂质体、阳离子脂质体、隐形脂质体、免疫脂质体
  • 按类型细分：奈米颗粒
  • 聚合物奈米颗粒、脂质奈米颗粒、金属奈米颗粒、奈米晶体
  • 按类型细分：微球
  • 可生物降解微球、磁性微球、放射性微球、黏膜黏附微球
  • 按类型细分：水凝胶
  • 热敏水凝胶、pH响应水凝胶、注射型水凝胶、智慧水凝胶
  • 按类型细分：树状聚合物
  • PAMAM树状聚合物、PPI树状聚合物、PEG化树状树状聚合物、杂化树状聚合物

第十章 区域与国家分析

  • 全球新型药物递送系统市场：区域分析、预测与趋势（2020-2025年、2025-2030年预测、2035年预测）
  • 全球新型药物递送系统市场：国家/地区、市场表现及预测（2020-2025年、2025-2030年预测、2035年预测）

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 新型药物递送系统市场：竞争格局及市场占有率（2024年）
  • 新型药物递送系统市场：公司估值矩阵
  • 新型药物递送系统市场：公司概况
    • Pfizer Inc
    • Johnson And Johnson
    • F Hoffmann La Roche AG
    • Merck And Co Inc
    • AbbVie Inc

第37章：其他领先和创新企业

  • Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Gilead Sciences, Amgen Inc, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年新型药物输送系统市场：提供新机会的国家
  • 2030年新型药物输送系统市场：蕴藏新机会的细分市场
  • 2030年新型药物输送系统市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME3MNDDS01_G26Q1

Novel drug delivery systems are advanced pharmaceutical technologies aimed at improving the effectiveness, safety, bioavailability, and targeted delivery of medications by precisely controlling the rate, timing, and location of drug release in the body. These systems address the shortcomings of traditional delivery methods, enhance treatment outcomes, and boost patient adherence across diverse medical and therapeutic fields.

Key formulation types within novel drug delivery systems include liposomes, nanoparticles, microspheres, hydrogels, and dendrimers. Liposomes are spherical vesicles made of phospholipid bilayers that encapsulate drugs, allowing for targeted delivery, controlled release, and minimized drug toxicity. The delivery modes include targeted, controlled, and modulated drug delivery systems, which are administered through various routes such as oral, injectable, pulmonary, transdermal, and others. These systems are applied in multiple therapeutic areas including cancer, cardiovascular diseases, neurological disorders, infectious diseases, and autoimmune diseases, serving end-users like hospitals, specialty clinics, research centers, and more.

Tariffs have influenced the novel drug delivery systems market by increasing costs for imported raw materials such as polymers, lipids, and specialized nanoparticles, impacting overall manufacturing economics and pricing strategies. these effects are most pronounced in formulation types like liposomes and nanoparticles and across regions reliant on cross-border pharmaceutical supply chains, particularly asia-pacific and europe. however, tariffs are also encouraging localization of manufacturing, regional supply chain diversification, and domestic innovation, which may strengthen long-term market resilience and self-sufficiency.

The novel drug delivery systems market research report is one of a series of new reports from The Business Research Company that provides novel drug delivery systems market statistics, including novel drug delivery systems industry global market size, regional shares, competitors with a novel drug delivery systems market share, detailed novel drug delivery systems market segments, market trends and opportunities, and any further data you may need to thrive in the novel drug delivery systems industry. This novel drug delivery systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The novel drug delivery systems market size has grown rapidly in recent years. It will grow from $117.66 billion in 2025 to $129.45 billion in 2026 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to increasing prevalence of chronic diseases, limitations of conventional drug delivery methods, growth in oncology and biologics pipeline, rising healthcare expenditure, advancements in polymer and nanotechnology.

The novel drug delivery systems market size is expected to see strong growth in the next few years. It will grow to $187.53 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to surge in personalized and precision medicine, growing demand for targeted cancer therapies, increasing investment in pharmaceutical r&d, expansion of biologics and biosimilars, regulatory support for advanced drug delivery technologies. Major trends in the forecast period include expansion of targeted and personalized drug delivery, rising adoption of lipid and polymeric nanoparticles, growth in long-acting and controlled release formulations, increased focus on non-invasive and patient-centric delivery routes, accelerated r&d in combination and hybrid ndds platforms.

The increasing cases of neurological disorders are anticipated to drive growth in the novel drug delivery systems market. Neurological disorders like stroke involve the sudden loss of neurological function caused by interrupted blood flow to the brain, either through a blockage (ischemic stroke) or a blood vessel rupture (hemorrhagic stroke), resulting in brain damage and possible long-term impairments in cognition, sensation, or movement. Factors such as aging populations, the rising prevalence of lifestyle-related conditions including hypertension, diabetes, and obesity, as well as greater exposure to chronic stress and environmental risks, are contributing to the increase in neurological disorders. Novel drug delivery systems aid in treating these disorders by providing targeted and controlled delivery of medications across the blood-brain barrier. For example, in November 2024, the National Health Service (NHS) England reported that stroke admissions in England reached 111,137 in 2023/24, with the highest rise seen in the 50-59 age group, which had 12,533 new cases. Consequently, the growing incidence of neurological disorders is fueling the novel drug delivery systems market.

Leading companies in the novel drug delivery systems market are innovating with products like oral thin films to improve patient compliance and treatment effectiveness. Oral thin films are rapidly dissolving strips applied inside the mouth that deliver drugs directly into the bloodstream through the mucosal lining. For example, in February 2024, CD Formulation, a US pharmaceutical formulation company, introduced Oral Thin Film Technology. This technology enables quick drug absorption by bypassing the gastrointestinal tract and liver metabolism, making it ideal for patients who have difficulty swallowing. It also allows precise dosing and faster onset of effects, enhancing treatment accuracy and convenience across multiple therapies.

In April 2023, DifGen Pharmaceuticals LLC, a US-based pharmaceutical firm, acquired Aveva Drug Delivery Services Inc. for an undisclosed sum. This acquisition is intended to expand DifGen's expertise in complex dosage forms by adding US research and manufacturing capabilities for transdermal and thin film drug delivery systems. Aveva Drug Delivery Services Inc. specializes in transdermal drug delivery and oral dissolvable films.

Major companies operating in the novel drug delivery systems market are Pfizer Inc, Johnson And Johnson, F Hoffmann La Roche AG, Merck And Co Inc, AbbVie Inc, Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Gilead Sciences, Amgen Inc, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited, Catalent Inc, Evonik Industries AG

North America was the largest region in the novel drug delivery systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the novel drug delivery systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the novel drug delivery systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The novel drug delivery systems market consists of sales of implants, micelles, exosomes, prodrugs, nasal drug delivery devices, buccal drug delivery films, and ocular drug delivery inserts. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Novel Drug Delivery Systems Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses novel drug delivery systems market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for novel drug delivery systems ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The novel drug delivery systems market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Formulation Type: Liposomes; Nanoparticles; Microspheres; Hydrogels; Dendrimers
  • 2) By Mode Of Novel Drug Delivery System (NDDS): Targeted Drug Delivery Systems; Controlled Drug Delivery Systems; Modulated Drug Delivery Systems
  • 3) By Route: Oral Drug Delivery Systems; Injectable Drug Delivery Systems; Pulmonary Drug Delivery Systems; Transdermal Drug Delivery Systems; Other Routes
  • 4) By Therapeutic Area: Cancer; Cardiovascular Diseases; Neurological Disorders; Infectious Diseases; Autoimmune Diseases
  • 5) By End-User: Hospital; Specialty Clinics; Research Centers; Other End-Users
  • Subsegments:
  • 1) By Liposomes: PEGylated Liposomes; Cationic Liposomes; Stealth Liposomes; Immunoliposomes
  • 2) By Nanoparticles: Polymeric Nanoparticles; Lipid Nanoparticles; Metallic Nanoparticles; Nanocrystals
  • 3) By Microspheres: Biodegradable Microspheres; Magnetic Microspheres; Radioactive Microspheres; Mucoadhesive Microspheres
  • 4) By Hydrogels: Thermosensitive Hydrogels; Ph-Responsive Hydrogels; Injectable Hydrogels; Smart Hydrogels
  • 5) By Dendrimers: PAMAM Dendrimers; PPI Dendrimers; Pegylated Dendrimers; Hybrid Dendrimers
  • Companies Mentioned: Pfizer Inc; Johnson And Johnson; F Hoffmann La Roche AG; Merck And Co Inc; AbbVie Inc; Bayer AG; Sanofi SA; Bristol Myers Squibb Company; AstraZeneca PLC; Novartis AG; GlaxoSmithKline PLC; Takeda Pharmaceutical Company Limited; Eli Lilly And Company; Gilead Sciences; Amgen Inc; Teva Pharmaceutical Industries Ltd; Otsuka Pharmaceutical Co Ltd; Regeneron Pharmaceuticals; Samyang Holdings Corporation; Galen Limited; Catalent Inc; Evonik Industries AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Novel Drug Delivery Systems Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Novel Drug Delivery Systems Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Novel Drug Delivery Systems Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Novel Drug Delivery Systems Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Industry 4.0 & Intelligent Manufacturing
    • 4.1.5 Sustainability, Climate Tech & Circular Economy
  • 4.2. Major Trends
    • 4.2.1 Expansion Of Targeted And Personalized Drug Delivery
    • 4.2.2 Rising Adoption Of Lipid And Polymeric Nanoparticles
    • 4.2.3 Growth In Long-Acting And Controlled Release Formulations
    • 4.2.4 Increased Focus On Non-Invasive And Patient-Centric Delivery Routes
    • 4.2.5 Accelerated R&D In Combination And Hybrid Ndds Platforms

5. Novel Drug Delivery Systems Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Specialty Clinics
  • 5.3 Pharmaceutical Companies
  • 5.4 Biotechnology Companies
  • 5.5 Research Centers

6. Novel Drug Delivery Systems Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Novel Drug Delivery Systems Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Novel Drug Delivery Systems PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Novel Drug Delivery Systems Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Novel Drug Delivery Systems Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Novel Drug Delivery Systems Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Novel Drug Delivery Systems Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Novel Drug Delivery Systems Market Segmentation

  • 9.1. Global Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Liposomes, Nanoparticles, Microspheres, Hydrogels, Dendrimers
  • 9.2. Global Novel Drug Delivery Systems Market, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, Modulated Drug Delivery Systems
  • 9.3. Global Novel Drug Delivery Systems Market, Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oral Drug Delivery Systems, Injectable Drug Delivery Systems, Pulmonary Drug Delivery Systems, Transdermal Drug Delivery Systems, Other Routes
  • 9.4. Global Novel Drug Delivery Systems Market, Segmentation By Therapeutic Area, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer, Cardiovascular Diseases, Neurological Disorders, Infectious Diseases, Autoimmune Diseases
  • 9.5. Global Novel Drug Delivery Systems Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Specialty Clinics, Research Centers, Other End-Users
  • 9.6. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Liposomes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PEGylated Liposomes, Cationic Liposomes, Stealth Liposomes, Immunoliposomes
  • 9.7. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Nanoparticles, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymeric Nanoparticles, Lipid Nanoparticles, Metallic Nanoparticles, Nanocrystals
  • 9.8. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Microspheres, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Biodegradable Microspheres, Magnetic Microspheres, Radioactive Microspheres, Mucoadhesive Microspheres
  • 9.9. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Hydrogels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Thermosensitive Hydrogels, Ph-Responsive Hydrogels, Injectable Hydrogels, Smart Hydrogels
  • 9.10. Global Novel Drug Delivery Systems Market, Sub-Segmentation Of Dendrimers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • PAMAM Dendrimers, PPI Dendrimers, Pegylated Dendrimers, Hybrid Dendrimers

10. Novel Drug Delivery Systems Market Regional And Country Analysis

  • 10.1. Global Novel Drug Delivery Systems Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Novel Drug Delivery Systems Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Novel Drug Delivery Systems Market

  • 11.1. Asia-Pacific Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Novel Drug Delivery Systems Market

  • 12.1. China Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Novel Drug Delivery Systems Market

  • 13.1. India Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Novel Drug Delivery Systems Market

  • 14.1. Japan Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Novel Drug Delivery Systems Market

  • 15.1. Australia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Novel Drug Delivery Systems Market

  • 16.1. Indonesia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Novel Drug Delivery Systems Market

  • 17.1. South Korea Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Novel Drug Delivery Systems Market

  • 18.1. Taiwan Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Novel Drug Delivery Systems Market

  • 19.1. South East Asia Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Novel Drug Delivery Systems Market

  • 20.1. Western Europe Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Novel Drug Delivery Systems Market

  • 21.1. UK Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Novel Drug Delivery Systems Market

  • 22.1. Germany Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Novel Drug Delivery Systems Market

  • 23.1. France Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Novel Drug Delivery Systems Market

  • 24.1. Italy Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Novel Drug Delivery Systems Market

  • 25.1. Spain Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Novel Drug Delivery Systems Market

  • 26.1. Eastern Europe Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Novel Drug Delivery Systems Market

  • 27.1. Russia Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Novel Drug Delivery Systems Market

  • 28.1. North America Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Novel Drug Delivery Systems Market

  • 29.1. USA Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Novel Drug Delivery Systems Market

  • 30.1. Canada Novel Drug Delivery Systems Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Novel Drug Delivery Systems Market

  • 31.1. South America Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Novel Drug Delivery Systems Market

  • 32.1. Brazil Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Novel Drug Delivery Systems Market

  • 33.1. Middle East Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Novel Drug Delivery Systems Market

  • 34.1. Africa Novel Drug Delivery Systems Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Novel Drug Delivery Systems Market, Segmentation By Formulation Type, Segmentation By Mode Of Novel Drug Delivery System (NDDS), Segmentation By Route, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Novel Drug Delivery Systems Market Regulatory and Investment Landscape

36. Novel Drug Delivery Systems Market Competitive Landscape And Company Profiles

  • 36.1. Novel Drug Delivery Systems Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Novel Drug Delivery Systems Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Novel Drug Delivery Systems Market Company Profiles
    • 36.3.1. Pfizer Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Johnson And Johnson Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. F Hoffmann La Roche AG Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Merck And Co Inc Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. AbbVie Inc Overview, Products and Services, Strategy and Financial Analysis

37. Novel Drug Delivery Systems Market Other Major And Innovative Companies

  • Bayer AG, Sanofi SA, Bristol Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Eli Lilly And Company, Gilead Sciences, Amgen Inc, Teva Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Regeneron Pharmaceuticals, Samyang Holdings Corporation, Galen Limited

38. Global Novel Drug Delivery Systems Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Novel Drug Delivery Systems Market

40. Novel Drug Delivery Systems Market High Potential Countries, Segments and Strategies

  • 40.1 Novel Drug Delivery Systems Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Novel Drug Delivery Systems Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Novel Drug Delivery Systems Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer